Your browser doesn't support javascript.
loading
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study.
Güven, Deniz Can; Yildirim, Hasan Çagri; Erul, Enes; Sahin, Taha Koray; Çakir, Ibrahim Yahya; Aktepe, Oktay Halit; Kertmen, Neyran; Dizdar, Ömer; Aksoy, Sercan.
Afiliação
  • Güven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Yildirim HÇ; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Erul E; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Sahin TK; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Çakir IY; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Aktepe OH; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Kertmen N; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Dizdar Ö; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  • Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Turk J Med Sci ; 52(5): 1551-1558, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36422490
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article